# OnCo record aquila (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/aquila/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "aquila", "NCT03301220" ;
  schema:name "AQUILA"@en ;
  schema:description "AQUILA showed that treating high-risk smouldering myeloma with the antibody daratumumab, rather than waiting for it to turn into active disease, delayed that progression, making it the first drug shown in a randomised trial to hold back myeloma before it causes symptoms."@en ;
  schema:url <https://onco.cc/trials/aquila/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03301220> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/smouldering-myeloma/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:drugs <https://onco.cc/drugs/daratumumab/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:people <https://onco.cc/people/meletios-dimopoulos/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-aquila-daratumumab-smouldering-nejm-2025/> .